Filing Analysis
Aspen Aerogels, Inc. filed an 8-K to announce its financial results for the second quarter of 2026, which ended on June 30, 2026.
📋 Key Facts
- Reported date: August 6, 2026
- Reporting period: Q2 2026 (ended June 30, 2026)
- The filing includes a press release containing financial results and business developments via Exhibit 99.1.
- Information under 'Financial Outlook' is provided under Item 7.01 for Regulation FD purposes.
Aspen Aerogels announced that CFO Grant Thoele has assumed the additional role of Principal Accounting Officer, replacing Santhosh P. Daniel. The company also reported the staged restart of its East Providence manufacturing facility following an unspecified incident and received stockholder support for declassifying its Board of Directors.
🚩 Red Flags
- Consolidation of CFO and Principal Accounting Officer roles following the departure of the Chief Accounting Officer.
- Disclosure of an 'incident' at the primary manufacturing facility requiring an ongoing investigation and external manufacturing support.
- Multiple 8-K items (5.02, 5.07, 7.01) filed simultaneously.
📋 Key Facts
- Grant Thoele (CFO) designated as Principal Accounting Officer effective May 13, 2026, replacing Santhosh P. Daniel.
- Thoele's annual base salary increased to $425,000 effective April 1, 2026.
- The East Providence, Rhode Island manufacturing facility is beginning a staged restart following an 'incident' and 'ongoing investigation'.
- Stockholders approved a non-binding proposal to declassify the Board of Directors at the May 13, 2026, Annual Meeting.
- KPMG LLP was ratified as the independent auditor for the fiscal year ending December 31, 2026.
Aspen Aerogels, Inc. reported its financial results for the first quarter ended March 31, 2026. The filing includes a press release with business developments and a financial outlook for the company.
📋 Key Facts
- The report covers the first quarter of 2026, which ended on March 31, 2026.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
- A press release containing the full announcement was attached as Exhibit 99.1.
- The company provided a 'Financial Outlook' section within the furnished materials.
Aspen Aerogels provided an update regarding an explosion at its East Providence, Rhode Island manufacturing facility that occurred on April 8, 2026. As of April 21, 2026, the facility remains offline, and the company is currently assessing the impact on its financial performance and ability to meet customer demand.
🚩 Red Flags
- Extended operational shutdown of a primary manufacturing facility (13+ days).
- Potential inability to meet customer demand due to production cessation.
- Industrial accident involving an explosion and employee injuries.
📋 Key Facts
- An explosion occurred at the East Providence facility on April 8, 2026, originating in a high-temperature oven.
- The facility remains completely offline as of the reporting date, April 21, 2026.
- Eleven employees were transported to medical facilities and subsequently released.
- The company has initiated claims for business interruption and property damage insurance.
- A further update on the financial impact is expected during the Q1 2026 earnings release in early May.
Aspen Aerogels announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The filing includes a press release detailing the company's performance and future financial outlook.
📋 Key Facts
- Announced Q4 and fiscal year 2025 results on February 25, 2026.
- Included Item 2.02 for results of operations and Item 7.01 for financial outlook disclosure.
- The financial period ended December 31, 2025.
- Grant Thoele, CFO and Treasurer, signed the report.
Aspen Aerogels, Inc. entered into Amendment No. 2 to its Credit, Security and Guaranty Agreement with MidCap Funding IV Trust. The amendment modifies liquidity thresholds and removes EBITDA maintenance covenants.
🚩 Red Flags
- Increased liquidity requirement: The change from 85% to 100% of the Term Loan principal as a minimum liquidity floor significantly raises the cash cushion required by lenders.
- Reduced acquisition basket: Limits the company's ability to use debt capacity for M&A activity.
📋 Key Facts
- Amendment No. 2 was entered into on December 16, 2025.
- Minimum liquidity threshold changed from the greater of $50M or 85% of outstanding principal to the greater of $50M or 100% of outstanding principal.
- The minimum EBITDA financial maintenance covenant has been removed entirely.
- Mandatory prepayment provisions for asset sale proceeds were revised to reduce required amortization payments in order of maturity.
- The basket for making permitted acquisitions under the facility was reduced.
Aspen Aerogels, Inc. filed an 8-K to announce its third quarter 2025 financial results for the period ending September 30, 2025.
📋 Key Facts
- Reported date: November 6, 2025
- Reporting period: Third Quarter 2025 (ended Sept 30, 2025)
- The filing includes financial results and business developments via a press release (Exhibit 99.1).
- Includes updated '2025 Financial Outlook' under Regulation FD disclosure.
Aspen Aerogels, Inc. announced the promotion of Grant Thoele to Chief Financial Officer and Treasurer, effective October 1, 2025, succeeding current CFO Ricardo C. Rodriguez.
🚩 Red Flags
- Change in key executive leadership (CFO) can sometimes signal internal friction or transition stress, though this is framed as a promotion of an existing employee.
📋 Key Facts
- Grant Thoele promoted to CFO and Treasurer effective October 1, 2025.
- Ricardo C. Rodriguez is stepping down from the CFO role.
- Thoele's annual base salary will be $390,000 with a performance bonus target of at least 60% of base salary.
- Promotion equity grant totaling $300,000 to be issued in October 2025 (split between PSUs, RSUs, and stock options).
- Employment agreement includes standard 'cause' and 'good reason' termination provisions.
Aspen Aerogels, Inc. announced its Q2 2025 financial results and a transition in the Chief Financial Officer role to an internal successor. The filing includes updated financial outlooks for the second half of 2025.
🚩 Red Flags
- Unexpected CFO departure/transition during a period of providing new financial guidance
📋 Key Facts
- Reporting date: August 7, 2025
- Financial results announced for Q2 2025 (ended June 30, 2025)
- CFO transition announced involving an internal successor
- Company provided a financial outlook for the second half of 2025
Aspen Aerogels, Inc. announced its financial results for the first quarter of 2025 ended March 31, 2025, and provided a financial outlook for the second quarter of 2025.
📋 Key Facts
- Reported Q1 2025 financial results on May 8, 2025.
- Provided 'Q2 2025 Financial Outlook' via Regulation FD disclosure.
- The filing includes a press release as Exhibit 99.1.
Aspen Aerogels, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on April 30, 2025. The meeting resulted in the election of two directors and the ratification of KPMG LLP as independent auditors.
📋 Key Facts
- Annual Meeting held on April 30, 2025, with an 83.31% quorum (68,402,761 shares present/represented).
- Kathleen M. Kool and William P. Noglows were elected to the Board as Class II directors.
- KPMG LLP was ratified as the independent registered public accounting firm for fiscal year ending Dec 31, 2025.
- Stockholders approved the Amended and Restated 2023 Equity Incentive Plan, increasing reserved shares by 3,850,000.
- Stockholders approved the Employee Stock Purchase Plan (ESPP) with 4,000,000 shares authorized for issuance.
Aspen Aerogels, Inc. announced the approval of new long-term incentive awards for its CEO and key executive officers. The plan introduces Performance Share Units (PSUs) designed to align executive compensation with total stockholder return relative to the Russell 2000 Index.
📋 Key Facts
- The Board approved PSU Awards for CEO Donald R. Young on March 5, 2025.
- Other key executives including CFO Ricardo C. Rodriguez and CLO Virginia H. Johnson were granted PSUs on March 4, 2025.
- PSU awards represent 50% of the total 2025 long-term incentive opportunity for named executive officers.
- The remaining 50% is split between Restricted Stock Units (25%) and stock options (25%).
- Performance period: January 1, 2025, through December 31, 2027.
- Payout scale: 0% to 200% of target based on TSR relative to the Russell 2000 Index components.
Aspen Aerogels, Inc. announced the planned retirement of two Board members, Rebecca B. Blalock and Mark L. Noetzel, effective after the 2025 Annual Meeting on April 30, 2025. The departures are part of a regular board refreshment process and will result in a reduction of the Board size from eight to six members.
🚩 Red Flags
- Reduction in Board size (from 8 to 6) may reduce the breadth of oversight, though framed as refreshment.
📋 Key Facts
- Rebecca B. Blalock and Mark L. Noetzel notified the Board of their intention to retire effective after the 2025 Annual Meeting on April 30, 2025.
- The departures are part of a 'regular Board refreshment process'.
- No disagreements with the Company regarding operations, policies, or practices were reported.
- Board size will decrease from eight members to six members.
- Committee leadership was rotated as part of an ordinary course review.
Aspen Aerogels, Inc. filed an 8-K to announce its financial results for the fourth quarter and full fiscal year ended December 31, 2024, alongside providing a financial outlook for Q1 2025.
📋 Key Facts
- Reported date: February 12, 2025
- Reporting period: Fourth quarter and fiscal year 2024 (ended Dec 31, 2024)
- Includes Q1 2025 Financial Outlook under Item 7.01 Regulation FD Disclosure
- Filed by CFO Ricardo C. Rodriguez
Aspen Aerogels, Inc. has adopted an amended and restated Code of Business Conduct and Ethics to replace its existing code as part of a routine policy review.
📋 Key Facts
- The Board of Directors approved the new Code on November 14, 2024.
- The amendment is part of an ordinary course review of company policies.
- The updated Code covers mission and values, reporting concerns, workplace conduct, trade compliance, and conflicts of interest.
- The amendment did not result in any waivers (explicit or implicit) of the existing Code.
Aspen Aerogels, Inc. filed an 8-K to announce its financial results for the third quarter of 2024, which ended September 30, 2024.
📋 Key Facts
- Reporting period: Third Quarter 2024 (ended September 30, 2024).
- Filing date: November 6, 2024.
- The filing includes a press release regarding financial results and business developments via Exhibit 99.1.
Aspen Aerogels, Inc. entered into an underwriting agreement to issue 4,250,000 shares of common stock at $20.00 per share. The offering is expected to generate approximately $85 million in gross proceeds to be used for working capital and capital expenditures.
🚩 Red Flags
- Potential dilution for existing shareholders due to the issuance of new common stock.
📋 Key Facts
- Aggregate shares to be issued: 4,250,000 shares of common stock
- Offering price: $20.00 per share
- Expected gross proceeds: $85 million (before discounts and expenses)
- Underwriters: Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC
- Underwriter option to purchase additional shares: 637,500 shares
- Expected closing date: October 23, 2024
- Use of proceeds: Working capital, capital expenditures, and general corporate purposes
Aspen Aerogels announced a conditional commitment from the U.S. Department of Energy (DOE) for a loan of up to $670.6 million to finance its second manufacturing facility in Georgia. The company also issued preliminary Q3 2024 financial results.
🚩 Red Flags
- The DOE commitment is 'conditional' and subject to technical, legal, environmental, and financial conditions before definitive financing is secured.
📋 Key Facts
- Received conditional commitment from the U.S. DOE Loan Programs Office.
- Proposed loan amount: up to $670.6 million under the Advanced Technology Vehicles Manufacturing program.
- Purpose of loan: financing construction of a second aerogel manufacturing facility in Register, Georgia.
- Loan borrower: Aspen Aerogels Georgia, LLC (a subsidiary).
- Repayment commences upon project commissioning; interest rate tied to U.S. Treasury Rate at time of cash draw.
- Release of preliminary Q3 2024 financial results via press release.
Aspen Aerogels, Inc. entered into an amended and restated employment agreement with its CEO, Donald R. Young, extending his term through August 30, 2027, with automatic one-year renewals.
🚩 Red Flags
- Significant severance obligations (2x salary + bonus) in the event of a 'Qualifying Termination'.
📋 Key Facts
- CEO Donald R. Young's term extended to end August 30, 2027 (previously expiring Dec 31, 2024).
- Annual base salary remains at $515,000.
- Target performance bonus is set at no less than 110% of base salary.
- Agreement includes a non-compete clause for one year following termination in exchange for 50% of highest annualized base salary over the prior 2 years.
- Qualifying termination benefits include 2x sum of base salary and bonus target if terminated without cause or by CEO for good reason.
Aspen Aerogels has executed a significant debt restructuring involving the repurchase of $123.9 million in Convertible Senior PIK Toggle Notes and the simultaneous entry into a new MidCap Loan Facility totaling up to $225 million (comprising a $125M term loan and a $100M revolving credit facility). This move effectively replaces existing debt with a new secured structure to fund the note repurchase and provide working capital.
🚩 Red Flags
- Significant increase in secured debt obligations to fund the repurchase of convertible notes.
- New financial covenants introduced: must maintain Liquidity $\ge$ $75 million and EBITDA $\ge$ specified amount (first test starts Q3 2024).
- The MidCap facility is secured by substantially all assets, increasing the company's leverage profile.
📋 Key Facts
- Repurchased $123,937,608 in aggregate principal of Convertible Senior PIK Toggle Notes due 2027 from Wood River Capital, LLC.
- Total cash consideration for Note Repurchase: $150,028,886 (includes PIK interest).
- Entered into MidCap Loan Facility consisting of a $125 million Term Loan and up to $100 million Revolving Credit Facility.
- MidCap Term Loan bears interest at Term SOFR + 4.50% (floor 4.50%, cap 7.50%).
- New debt is secured by a lien on substantially all existing and future assets of the Company and Aspen RI.
- Wood River Capital agreed to a 180-day non-transfer/non-sale restriction on Company common stock.
- Terminated and fully paid off an existing $100 million loan agreement with General Motors Holdings LLC.
Aspen Aerogels, Inc. announced the appointment of Cari Robinson to its Board of Directors as a Class I director, effective August 14, 2024. Ms. Robinson will also serve on the Audit Committee and the Nominating, Governance and Sustainability Committee.
📋 Key Facts
- Cari Robinson appointed to the Board as a Class I director until the 2027 Annual Meeting of Stockholders.
- Appointed to both the Audit Committee and the Nominating, Governance and Sustainability Committee.
- Ms. Robinson is considered an independent director.
- Compensation includes an annual board retainer of $45,000, $7,500 for Audit Committee service, and $4,000 for Nominating/Governance/Sustainability Committee service.
- Initial equity grant consists of $44,340 in restricted stock and $26,921 in stock options, vesting on May 30, 2025, or upon a Change in Control.
- Ms. Robinson has extensive legal and cybersecurity background, including roles at IBM and Revlon, Inc.
Aspen Aerogels, Inc. filed an 8-K to announce its second quarter 2024 financial results and provide a business update for the period ending June 30, 2024.
📋 Key Facts
- Reported financial results for Q2 2024 (ended June 30, 2024).
- The filing includes an announcement of '2024 Financial Outlook'.
- Filed on August 7, 2024.
- Includes Exhibit 99.1 containing the press release.
Aspen Aerogels, Inc. issued an 8-K to provide a press release regarding recent business developments and to reaffirm its financial outlook for the fiscal year ending December 31, 2024.
📋 Key Facts
- The filing was made on June 13, 2024.
- The company is reaffirming its financial guidance/outlook for the full fiscal year 2024.
- The announcement includes recent developments regarding the company's business operations.
Aspen Aerogels, Inc. held its 2024 annual meeting of stockholders on May 30, 2024. The company reported high quorum participation and successfully completed routine governance actions including director elections and auditor ratification.
📋 Key Facts
- Annual Meeting held via live audio webcast on May 30, 2024.
- Quorum achieved: 70,180,009 shares (92.2% of eligible shares).
- Elected Rebecca B. Blalock and James E. Sweetnam to the Board of Directors as Class I directors until 2027.
- Ratified the appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Stockholders approved non-binding advisory vote on executive compensation (Say-on-Pay) with 42,702,743 votes in favor.
Aspen Aerogels, Inc. filed an 8-K to announce its financial results for the first quarter of 2024 ended March 31, 2024.
📋 Key Facts
- Reporting period: Q1 2024 (ended March 31, 2024).
- Announcement date: May 1, 2024.
- The filing includes a press release containing financial results and business developments via Exhibit 99.1.
Aspen Aerogels, Inc. announced the cancellation of unearned performance-based restricted shares for several key executives, including the CEO and CFO, effective March 6, 2024. The company determined that achieving the remaining performance hurdles was remote due to current market conditions.
🚩 Red Flags
- Significant performance hurdle failure: The company explicitly stated that achieving remaining hurdles is 'remote' due to market conditions, indicating a significant downturn in expected business metrics or stock performance.
- Executive compensation restructuring: Large-scale cancellation of equity for top leadership (CEO, CFO, CLO) often signals extreme difficulty in meeting corporate milestones.
📋 Key Facts
- The Compensation and Leadership Development Committee approved the cancellation of unearned performance-based restricted shares on March 5, 2024.
- CEO Donald R. Young had 304,666 unvested restricted shares cancelled.
- CFO Ricardo C. Rodriguez and several other SVPs had 53,590 unvested restricted shares cancelled each.
- The cancellation will result in an immediate charge of approximately $2.2 million in unamortized compensation costs.
- Cancelled shares were added back to the pool available under the Company’s 2023 Equity Incentive Plan.
Aspen Aerogels, Inc. filed an 8-K to announce its financial results for the fourth quarter and fiscal year ended December 31, 2023. The filing includes a press release detailing operational performance and providing a financial outlook for 2024.
📋 Key Facts
- Reported financial results for Q4 and FY 2023 on February 12, 2024.
- The filing includes '2024 Financial Outlook' under Item 7.01 (Regulation FD Disclosure).
- The report was signed by Ricardo C. Rodriguez, CFO and Treasurer.
Aspen Aerogels, Inc. issued a press release providing preliminary financial results for the fourth quarter and full year 2023, alongside an initial financial outlook for 2024.
📋 Key Facts
- Report date: January 11, 2024
- The filing includes preliminary financial information for Q4 and FY 2023
- The company provided a preliminary 2024 financial outlook
- Information was released via press release (Exhibit 99.1) under Items 2.02 and 7.01